Decreased transplant arteriosclerosis in endothelial nitric oxide synthase-deficient mice

Transplantation. 2010 Mar 15;89(5):518-26. doi: 10.1097/TP.0b013e3181c7dce4.

Abstract

Background: Occlusive vascular changes, characterized by the formation of a neointima with lumen obstruction, are key histologic findings of allograft arteriosclerosis. Vascular integrity of the graft is critically dependent on nitric oxide (NO), synthesized by NO synthases (NOS), of which three isoforms have been located in the arterial wall: endothelial NOS (eNOS), inducible NOS, and neuronal NOS (nNOS). We have studied the role of NOS in a murine model of aortic allograft rejection.

Methods: The descending thoracic aorta of donor mice (BALB/c mice) was transplanted into two groups of recipients: (a) C57BL/6J and (b) C57BL/6J mice homozygous (-/-) for a knockout of the eNOS gene (eNOS(-/-)).

Results: After 4 weeks, pronounced neointima formation, upregulated expression of adhesion molecules, and increased infiltration by inflammatory cells were demonstrated in wild-type recipient mice, whereas eNOS(-/-) recipient mice were protected from neointima development by a significantly increased synthesis of NO, as shown by increased formation of cGMP; this was mainly explained by upregulation of inducible NOS and nNOS.

Conclusions: Upregulation of inducible NOS and nNOS isoforms may be beneficial in preventing allograft arteriosclerosis in the early posttransplant period.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta, Thoracic / transplantation*
  • Arteriosclerosis / prevention & control*
  • Cell Adhesion
  • Cell Division
  • Cyclic GMP / metabolism
  • DNA Primers
  • Homozygote
  • Kidney / enzymology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout / genetics
  • Myocardium / enzymology
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type I / genetics
  • Nitric Oxide Synthase Type III / deficiency*
  • Nitric Oxide Synthase Type III / genetics
  • Postoperative Complications / prevention & control
  • RNA / genetics
  • RNA / isolation & purification
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tunica Intima / pathology

Substances

  • DNA Primers
  • Nitric Oxide
  • RNA
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type III
  • Cyclic GMP